Impacting Insomnia in Practice to Improve Quality of Life is organized by National Association for Continuing Education (NACE).
Start Date: 12/31/2019
Expiration Date: 12/30/2020
Accreditation:
The National Association for Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1.0 contact hour of continuing education which includes 0.75 pharmacology hours.
Course Description:
Insomnia, a common but often neglected condition in primary care, has long-term and serious effects on the health of patients. However, it remains undertreated and underdiagnosed. Fortunately, new discoveries have been made about the sleep wake cycle and the neurobiology of sleep along with new and emerging pharmacological treatment agents. This activity will discuss the basic neurobiology of sleep and wakefulness, the impact on health and quality of life, and strategies to individualize treatment specific to patients’ symptom patterns.
Learning Objectives:
Upon completion of this course, learners should be able to:
• Discuss the basic neurobiology of sleep and wakefulness
• Recognize the global impact of insomnia on patient quality of life and comorbidities
• Enumerate the mechanisms of action of traditional and novel pharmacological agents and understand their potential clinical indications
• Develop an evidence-based process in the selection and use of pharmacological and non-pharmacologic modalities in the treatment of insomnia
Additional details will be posted as soon as information is available.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved